Highest-materiality recent filing
Milestone Scientific appoints two independent directors and names new Executive Chairman
Benedetta Casamento transitions from Board Chair to Executive Chairman, receiving $75,000 annual salary and $100,000 restricted stock grant.
Milestone Scientific reprices CEO & SVP options and proposes PRSU plan with up to 17.2M shares
CEO Eric Hines and SVP Jason Papes surrender options at $0.46-$0.50 for new options at $0.31 exercise price.
Milestone Scientific dismisses auditor CBIZ; engages Grassi & Co. effective May 15, 2026
CBIZ CPAs' 2025 audit report included a going concern explanatory paragraph about substantial doubt.
Milestone Scientific closes $2.15M private placement of units at $0.27/unit
Issued 7,962,963 units, each consisting of one common share and one warrant (exercise $0.3375, 3-yr term).
MLSS enters amended MoU locking up ~8.9M BP4 shares for 12 months post-$2.5M qualified offering
BP4 (controlled by Innovest) agrees to lock up ~8.9M shares of MLSS for 12 months after a Qualified Offering raising at least $2.5M.
Milestone Scientific receives NYSE American delisting notice for non-compliance
Received NYSE American letter on Oct 8, 2025, citing non-compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.
Milestone Scientific appoints Eric Hines as CEO; compensation includes options for 2M shares
Eric Hines named President and CEO effective July 31, 2025; also appointed to the Board.
CEO Arjan Haverhals retires as officer on Dec 31, 2024; remains director and consultant through family company.
Milestone Scientific nets $1.98M from selling NOLs and R&D credits to Comcast
Received net $1,983,095 from Comcast Corporation on April 8, 2024 for unused NOLs and R&D tax credits.
Milestone Scientific prices $3M public offering of 4.765M shares at $0.63 per share
Offering of 4,765,000 common shares at $0.63/share; gross proceeds ~$3.0 million.
Milestone Scientific CFO Peter J. Milligan resigns effective Sept 1, 2023
CFO Peter J. Milligan resigns effective September 1, 2023, citing decision to pursue other opportunities.
On June 19, 2026, the Board of Directors of the Company unanimously appointed, by the directors in attendance, Kelly Ulto and Greg Shilling as independent directors of the Company.
On June 19, 2026, the Board of Directors of the Company unanimously appointed, by the directors in attendance, Kelly Ulto and Greg Shilling as independent directors of the Company.
Shanth Thiyagalingam, a member of the Board of Directors (the “Board”) since 2025, was nominated to continue as a director but has advised the Company that he has decided to devote his full time as chief executive officer of PainTEQ and to his family, and not to run for re-election.
electing Ms. Casamento as Executive Chairman.
On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.
On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.
Mr. Neal Goldman, the Chairman of the Board of Directors of the Company, has been appointed the Interim Chief Executive Officer, effective on Mr. Haverhals retirement.
On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.
On September 6, 2023, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Dr. Didier Demesmin as an independent director of the Company.
On August 24, 2023, Milestone Scientific Inc. (the “Company”) announced that Peter J. Milligan, the Company’s part-time Chief Financial Officer, resigned effective September 1, 2023.
On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.
On January 4, 2023, Leslie Bernhard tendered her resignation to Milestone Scientific Inc. (the "Company") as a director, Chairman of the Audit Committee and Chairman of the Board of the Company.
Max materiality 0.80 · Median 0.40 · Most common event other_material